The tone is definitely better than in November last year re a deal. Although commercial transaction could be anything .
Novartis is on the hunt for a stable of solutions to add to patches etc .
If you asked me to throw blindfold dart I think it's a license agreement w Novartis. I think whoever wants the assets will want the core team at ivx . Keep em happy and they're shareholders like us . Just a hunch . Stab in the dark. I have no special knowledge here. The tech is just too good. Someone will pick it up. Sorry bears! I'm feeling v confident.
There is more money sloshing around in biotech . Fingers crossed .
IVX Price at posting:
0.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)